Trimodal Lung-Sparing Treatment of Pleural Mesothelioma
Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine the feasibility (as determined by lack of
serious adverse events) and tolerability (as determined by patient's ability to complete the
study) of a multimodal lung sparing regimen of surgery, interpleural and intravenous
chemotherapy, and local P-32 irradiation for malignant pleural mesothelioma.